BACKGROUND: Ovarian carcinoma represents about 4% of all cancers diagnosed in women worldwide. Mortality rate is high, over 50%, mainly due to late diagnosis. Currently there are no acceptable screening techniques available, although ovarian cancer belongs to the group of malignancies for which mortality could be dramatically reduced by early diagnosis.In a recently published study, we clearly demonstrated that human ovarian carcinoma tissues can be characterized by a specific odour, detectable by a trained dog. Another recent study confirmed these results using an electronic nose. METHODS: In the present work, we examined whether the cancer-specific odour can also be found in the blood. Two specially trained dogs were used. Both ovarian cancer tissues and blood from patients with ovarian carcinoma were tested. RESULTS: The tissue tests showed sensitivity of 100% and specificity of 95%, while the blood tests showed sensitivity of 100% and specificity of 98%. CONCLUSIONS: The present study strongly suggests that the characteristic odour emitted by ovarian cancer samples is also present in blood (plasma) taken from patients with the disease. This finding opens possibilities for future screening of healthy populations for early diagnosis of ovarian carcinoma. A future challenge is to develop a sensitive electronic nose for screening of ovarian carcinoma by testing the blood/plasma to detect the disease at a stage early enough for treatment to be effective.
BACKGROUND:Ovarian carcinoma represents about 4% of all cancers diagnosed in women worldwide. Mortality rate is high, over 50%, mainly due to late diagnosis. Currently there are no acceptable screening techniques available, although ovarian cancer belongs to the group of malignancies for which mortality could be dramatically reduced by early diagnosis.In a recently published study, we clearly demonstrated that humanovarian carcinoma tissues can be characterized by a specific odour, detectable by a trained dog. Another recent study confirmed these results using an electronic nose. METHODS: In the present work, we examined whether the cancer-specific odour can also be found in the blood. Two specially trained dogs were used. Both ovarian cancer tissues and blood from patients with ovarian carcinoma were tested. RESULTS: The tissue tests showed sensitivity of 100% and specificity of 95%, while the blood tests showed sensitivity of 100% and specificity of 98%. CONCLUSIONS: The present study strongly suggests that the characteristic odour emitted by ovarian cancer samples is also present in blood (plasma) taken from patients with the disease. This finding opens possibilities for future screening of healthy populations for early diagnosis of ovarian carcinoma. A future challenge is to develop a sensitive electronic nose for screening of ovarian carcinoma by testing the blood/plasma to detect the disease at a stage early enough for treatment to be effective.
Authors: Lloyd H Smith; Cyllene R Morris; Shagufta Yasmeen; Arti Parikh-Patel; Rosemary D Cress; Patrick S Romano Journal: Cancer Date: 2005-10-01 Impact factor: 6.860
Authors: Michael McCulloch; Tadeusz Jezierski; Michael Broffman; Alan Hubbard; Kirk Turner; Teresa Janecki Journal: Integr Cancer Ther Date: 2006-03 Impact factor: 3.279
Authors: Robert T Gordon; Carole Beck Schatz; Lawrence J Myers; Michael Kosty; Constance Gonczy; Joan Kroener; Michael Tran; Pamela Kurtzhals; Susan Heath; James A Koziol; Nan Arthur; Madeline Gabriel; Judy Hemping; Gordon Hemping; Sally Nesbitt; Lydia Tucker-Clark; Jennifer Zaayer Journal: J Altern Complement Med Date: 2008 Jan-Feb Impact factor: 2.579
Authors: Avinash Bajaj; Oscar R Miranda; Ik-Bum Kim; Ronnie L Phillips; D Joseph Jerry; Uwe H F Bunz; Vincent M Rotello Journal: Proc Natl Acad Sci U S A Date: 2009-06-23 Impact factor: 11.205
Authors: Edward Partridge; Aimee R Kreimer; Robert T Greenlee; Craig Williams; Jian-Lun Xu; Timothy R Church; Bruce Kessel; Christine C Johnson; Joel L Weissfeld; Claudine Isaacs; Gerald L Andriole; Sheryl Ogden; Lawrence R Ragard; Saundra S Buys Journal: Obstet Gynecol Date: 2009-04 Impact factor: 7.623
Authors: Martin Strauch; Alja Lüdke; Daniel Münch; Thomas Laudes; C Giovanni Galizia; Eugenio Martinelli; Luca Lavra; Roberto Paolesse; Alessandra Ulivieri; Alexandro Catini; Rosamaria Capuano; Corrado Di Natale Journal: Sci Rep Date: 2014-01-06 Impact factor: 4.379
Authors: Claire Guest; Rob Harris; Karen S Sfanos; Eva Shrestha; Alan W Partin; Bruce Trock; Leslie Mangold; Rebecca Bader; Adam Kozak; Scott Mclean; Jonathan Simons; Howard Soule; Thomas Johnson; Wen-Yee Lee; Qin Gao; Sophie Aziz; Patritsia Maria Stathatou; Stephen Thaler; Simmie Foster; Andreas Mershin Journal: PLoS One Date: 2021-02-17 Impact factor: 3.240
Authors: Marije K Bomers; Michiel A van Agtmael; Hotsche Luik; Merk C van Veen; Christina M J E Vandenbroucke-Grauls; Yvo M Smulders Journal: BMJ Date: 2012-12-13